Background and purpose: The European Association of Palliative Care Task-force, in S P P C N E
Introduction
The care of people with progressive neurological dis-eases is a challenge for all involved in neurology, neurorehabilitation, general medicine and palliative care [1] . The mortality from neurological disease is increasing across Europe and progressive degenerative neurological disease is an important cause of both morbidity and disability in Europe [2] . Although there are similarities in progression, there are also factors for each disease, and every person will present and progress in their own individual way.
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of 110 180/ 100 000), multiple sclerosis (MS) (80 140/100 000amyotrophic lateral sclerosis (ALS) (6 H and progressive supranuclear palsy (7/100 000) [3] . Stroke and primary brain tumours will also be considered within this consensus review as in many parts of Europe they come under the neurological services and present similar dilemmas in management and care. Dementia is not considered E A care has been included within previous guidelines across many categories of progressive neurological disease.
The care of a person with progressive neurological disease will initially be within neurological services when the diagnosis is made and initial treatment is initiated. The ongoing management of progressive neurological disease varies across Europe and can be within neurological services, neurorehabilitation, palliative care, general medical services, geriatric medicine or primary care. There is increasing involvement of palliative care services and closer collaboration with neurological services, often soon after diagnosis of a progressive disease. Palliative care provides a holistic assessment of the patient and family, considering the physical, psychological, social and spiritual aspects with a multidisciplinary team approach [7] . However, the involvement and availability of palliative care varies across Europe between and within countries varying involvement in non-malignant disease. Palliative care is now often considered for patients with cancer but the importance of palliative care for non-malignant disease is still developing.
The European Association of Palliative Care (EAPC) formed a taskforce to look at the palliative care within neurological disease in 2008. A collaborative approach has been undertaken with the Scien Panel on Palliative Care of the European Federation of Neurological Societies (EFNS) now amalgamated within the European Academy of Neurology (EAN) to develop this paper, reviewing the evidence for the management of progressive neurological disease with the aim of establishing a consensus for recommendations on palliative and end of life care for these patients and their families. A common approach between neurology and palliative care can develop leading to a more collaborative approach to care. The EAPC and EAN are committed to increasing collabo-ration, with the aim of improving the care of people with neurological disease as the disease progresses and end of life approaches. This paper aims to provide evidence for the palliative care of people with neuro-logical disease, considering all aspects of their progression.
Methods search strategy
The search included literature on palliative care involvement in other disease groups, as we thought that there could be appropriate evidence from other areas of care. 
terms in points 2 and 3. The results of these three combinations were then combined with AND T establish the widest review of palliative care involvement in neuro-logical disease. All studies were included and the papers related primarily to neurological patients, but studies of other disease groups relevant to neurological patients were included.
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2015, with extra references found on each occasion. The search details are shown in Fig. 1 . The references included were guidelines, meta-analyses, randomized controlled trials, cohort studies and case series, and those excluded were reviews, book chapters, case reports and those relating to disease groups other than neurology unless there was a clear relevance to neurological patients such as for communication with patients and families within the publication.
Methods for reaching consensus
Two investigators (DJO, RV) looked at the literature that considered the palliative care of people with advanced neurological disease or with other progressive diseases and determined the seven main areas and the subsections. These areas were suggested from the papers included in the review, using a grounded
Results
During the appraisal of the literature seven main areas were developed form the evidence found on the management of palliative care for neurological disease. These areas have been developed further by consensus within the group theory approach, without any particular or predetermined ideas. The investigators produced the areas of care supported by the draft list of papers giving the evidence for each area. These were circulated to the other authors. The next draft was disseminated for comment both on the areas considered and the strength of the evidence in the literature to a wider group of health professionals. The recommendations were agreed by all authors in an iterative process and are es paper of Brainin et al. [8] with C I IV L A e ective .. .), Level B (probably e ective .. .) and Level C (possibly e ective .. .). There were no disagreements during this process. The initial discussions took place before the GRADE system [9] was recommended for reviewing. In this preliminary approach the development of fully evidence-based guidelines was not feasible, and this is a framework based on the appropriate evidence to answer T , the lack of evidence for a merely that there is little strong evidence in the literature.
Early integration of palliative care
Research within neurological care is limited but there palliative care for patients with cancer, including early palliative care increasing length of survival and reducing hospital care for patients with lung cancer ( [10, 11] , both Class I). The development of guidelines suggesting the early integration of palliative care within cancer services has been helpful in encouraging earlier involvement ( [12] , Class IV).
Specialized palliative care team involvement has been shown to improve family satisfaction and symptom management and provide cost savings but the studies have limited evidence ( [13] , Class II).
Within the care of multiple sclerosis, early involvement of palliative care has been shown to improve symptom management and improve patient and family satisfaction ( [14] , Class II; [15] , Class IV). There is limited evidence that palliative care input improves symptoms and overall quality of life for patients with ALS, MS and PD/multiple system atrophy/progressive supranuclear palsy ( [16] , Class II).
T the diagnosis and depends on the natural history of the disease. ALS has an average life expectancy of 3 5 years from symptom onset, and the symptoms and disability experienced by the patient may be profound at or soon after diagnosis, so that palliative care is often appropriate from diagnosis onwards. PD has a longer prognosis with an average of 15 years. Thus, a palliative care approach may be helpful during the progression of the disease but palliative care services may have less involvement until later in the disease progression [16] .
Recommendation
Palliative care should be considered early in the disease trajectory, depending on the underlying diagnosis (Level C).
Multidisciplinary team
The involvement of a multidisciplinary team approach has been suggested in many reviews and guidelines [5] this was considered to be a team where each member contributes his/her expertise in close cooperation with the others and could include physician, nursing, psychology/social work and allied health professionals including physiotherapist, occupational therapist, dietitian and speech and language therapist. There is limited -ness of this approach, but in Ireland it was found that ALS patients receiving care at a multidisciplinary clinic had a better prognosis with a median survival 7.5 months longer than patients seen within general neurology clinics ( [17] , Class II; [18, 19] , Class III). A study on MS patients found increased satisfaction with multidisciplinary care ( [14] , Class II).
Recommendations
The assessment and care should be provided by a multidisciplinary team approach consisting of at least L C
Patients should have a multidisciplinary palliative care assessment and access to specialist palliative care for ongoing management (Level B).
Communication

Communication and goal setting
The telling of the diagnosis of a progressive neurological disease sets the agenda for the later care of the patient and family 
Recommendations
Communication with patients and families should be open, including the setting of goals and therapy options, and should be structured following validated models (Level C).
Early advance care planning is strongly recommended, especially when impaired communication and cognitive deterioration are possible as part of disease progression (Level C).
Symptom management
There is increasing evidence that palliative care involvement may improve both quality and length of life for people with cancer ( [10] , Class I). There is limited evidence of the improving quality of life or patient or family satisfaction but studies have shown an improvement in quality of life and symptoms and patient and family satisfaction for ALS ( [16] , Class II) and MS ( [14] , Class II). Recommendations P gnosis, pharmacological and nonpharmacological management and regular review (Good Practice Point).
Proactive assessment of physical and psychosocial issues is recommended to reduce the intensity, frequency and need for crisis intervention (unplanned care) (Level B).
The principles of symptom management, as part of the wider palliative care assessment, should be applied to neurological care (Level B).
Carer support
The care of a person with a progressive neurological disease often causes stress physical and emotional for carers, whether family or non-family carers. Coping with the relentless these losses may be the cause of depression and a reduced quality of life for the person ( 
Recommendations
The
Professionals involved in the care of progressive disease should receive education, support and supervision to reduce the risks of emotional exhaustion and burn-out (Level C).
End of life care
The recognition of deterioration in disease progression near the end of life is essential in enabling the provision of appropriate care and support for patients and their families. Regular reassessment is important, with careful continued discussion to enable the changes to be recognized ([45] , Class IV).
Triggers have been suggested for the recognition of end of life for patients with progressive neurological disease complex symptoms ([46], Class IV). These are being further evaluated but there is evidence that these triggers may help in the recognition of the end of life Class III). In PD there is evid suggest that palliative care should be considered ([48], Class III).
Although patients and families may have fears of a distressing death from progressive neurological dis-ease, there is evidence that this is rare with good palliative care and support ([49], Class IV). Families do appreciate honesty and awareness of deterioration. S experience of specialist palliative care, and death for the majority of patients is peaceful ([49,50], both Class IV).
Patients and families may wish to discuss hastened death by euthanasia or physicianassisted suicide ([51,52], Class IV). In the Netherlands up to 31% of people with ALS consider euthanasia or physician-assisted suicide, although 69% of these people follow this through ([53], Class IV). The availability of these options varies from country to country and in most areas they are not considered to be part of palliative care. However, the discussion of these issues should be open and can allow patients and families to talk of their fear and concerns about dying and death ([54,55], both Class IV). These patients may fear distress and pain during the dying process or may be wishing to retain control over their life and death, thus expressing their own autonomy ( 
Recommendations
Continued and repeated discussion with patients is essential due to changes in function physical and cognitive and preferences (Level C)
Encourage open discussion about the dying process and explain that most patients will die peacefully with appropriate care (Level C).
Encourage open discussion of wishes to restrict treatment and interventions and the wish for hastened death, and assess regularly (Level C).
Recognition of deterioration over the last weeks and months is relevant for the appropriate management (Level C).
The diagnosis of the start of the dying phase, although this may not always be possible, is relevant for the appropriate management, including the use of appropriate medication and intervention and care and support of families and carers (Level C).
Training and education
There is little in the education and training of medical students, doctors in training and neurologists, and the wider multidisciplinary team concerning the palliative care approach to patients and families ([46,62,63] , all Class IV), although there are examples of excellence [64] . Moreover, there is limited education in the care of patients with progressive neurological patients within the training of specialists in palliative medicine. These skills, particularly in communication ([20,64] , both Class I) can be learnt and there is evidence, particularly from the care of cancer patients, of the improvement in skills with the appropriate training and experience. A targeted education programme for health professionals improved understanding about end of life care for people with motor neurone disease ([65], Class IV).
Recommendations
Palliative care principles should be included in the training and continuing education of neurologists (Good Practice Point).
The understanding and management of neurological symptoms of patients in the advanced stages of neuro-logical diseases should be included in the training and continuing education of specialist palliative care professionals (Good Practice Point).
Conclusion
There is increasing evidence of the integration of palliative care in the care of patients with progressive neurological disorders [66] . This review shows that there is limited evidence for the provision of palliative care for patients with progressive neurological disease and the recommendations have limited support from the literature. However, there would appear to be increasing evidence that palliative care and an improved approach to the communication with and support of patients and their families does lead to improved care and patient experience.
There is increased awareness of the approaches with guidelines which have been developed across Europe [67] . For example in the UK NICE guidelines on the use of non-invasive ventilation in motor neurone disease [68] there is discussion about the need for the consideration of end of life issues throughout the process of monitoring and establishing treatment. In the European guidelines on ALS [6] palliative and end of life care are highlighted as an important area of care.
However, there is pressing need to consider the role of palliative care in the management of all progressive neurological diseases. This will involve not only palliative care services and neurology but also primary care, rehabilitation services and other medical and professional services. There is particular interaction with rehabilitation medicine, as there is often an overlap in areas of care provided, particularly when there is a slowly progressive disease [67] . The issues of collabo-ration and interaction with other disciplines, and within disciplines, are from further research, with the aim of clarifying the most appropriate way of supporting patients and families, without adding to their interaction with multiple caring teams. This paper is a step in the ongoing development with the aim of encouraging all involved in this area of care to look at the most appropriate and evidence-based management so that the quality of life of patients and families can be maximized. As there was limited evidence from this review a further wide literature review and clear evidence-based approach using the G'ADE review. There would appear to be a lack of good evidence to support the recommendations and further research into this area of care is urgently needed.
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